ReviewBioengineering & translational medicine2026
Mechanical interplay between adipose tissues and disease progression.
Review in Bioengineering & translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Over the past two decades, an increasing body of evidence has underscored the significant role of the mechanical properties of biological tissues in maintaining tissue functions and regulating cellular changes, such as proliferation, migration, and differentiation. Throughout disease progression, such as in cancers, bone defects, and cardiac conditions, the mechanical microenvironment of tissues can undergo dramatic changes, exerting profound effects on disease development. Adipose tissues are inherently mechanosensitive and mechanoresponsive, continually exposed to various mechanical stresses in daily life. The hypertrophy and accumulation of adipocytes can lead to obesity, a condition strongly associated with numerous health risks, like diabetes and cancers. In this review, we aim to elucidate the reciprocal mechanical interaction between adipose tissues and disease progression, encompassing cancers, bone defects, and cardiac pathologies. The existing literature suggests that alterations in the mechanical microenvironment during disease advancement may impede adipogenic differentiation, induce adipocyte dedifferentiation, and escalate the secretion of inflammatory cytokines. Conversely, dysregulation of adipose tissues can result in the deposition of extracellular matrix components, stiffening the microenvironment and fostering disease progression in a cyclical fashion. Therefore, in future treatments of related diseases, a combined approach integrating mechanotherapeutics and obesity management holds promise for achieving the desired enhanced therapeutic outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.